Budget vs premium
Embody vs Maximus: Which Costs Less Over 12 Months? (2026)
Embody $69/mo vs Maximus $133/mo. 2026 comparison of pricing, medication and support, with 12-month totals rather than first-month offers.
Published · Pricing as published in our provider dataset, synced · Editorial scores 7.6 and 7.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
Anyone shortlisting Embody against Maximus is choosing between two direct-pay GLP-1 programs that solve the same problem in materially different ways.
On the number that matters after the first month, they are not close: Embody runs $69/mo against $133/mo at Maximus — 93% more, every month, for the same drug class.
Rather than restate two feature lists, this compares the two on cost over time, medication access, price stability and the support each one includes. Where a provider quotes only after intake, that is recorded as the answer rather than replaced with a guess.
The short answer
- Lowest 12-month cost
- Embody — $828 against $1,596 at Maximus, on each provider's own best published pricing.
- Most predictable bill
- Maximus — Flat rate at every dose, so titration does not change what you are charged.
- Tirzepatide access
- Embody — Tirzepatide at $119/mo; the other side publishes semaglutide only.
- Longest public track record
- Embody — 11,250 patient reviews against 2,896.
The short version: Embody vs Maximus
Two programs, side by side, on their own published terms — with the rows that differ doing the work.
| Embody | Maximus | |
|---|---|---|
| Advertised price | Semaglutide $69/mo (was $299), tirzepatide $119/mo | $132.99/mo |
| Rate after promotions | $69/mo | $133/mo |
| Pricing structure | Published rate per medication | Flat rate at every dose |
| Medication | Compounded semaglutide and compounded tirzepatide | Compounded semaglutide |
| Membership fee | None | None |
| Payment options | Card only, no financing published | Card only, no financing published |
| State coverage | Not published | Not published |
| How fast you start | Licensed provider review handled entirely online | Telemedicine intake, no clinic visits |
| Patient reviews | 11,250 | 2,896 |
| eRxDoctor score | 7.6/10 | 7.0/10 |
Embody vs Maximus on total cost, not entry price
A first-month price is a customer-acquisition number. The totals below are the honest version, built from the rates each provider publishes.
| Embody | Maximus | |
|---|---|---|
| First month | $69 | $133 |
| Months 2 onward | $69/mo | $133/mo |
| 6-month total | $414 | $798 |
| 12-month total | $828 | $1,596 |
| Best published plan | No multi-month discount published | No multi-month discount published |
Over a year that is a $768 difference, in Embody's favor. Whether it is the right call depends on whether Maximus gives you $64 a month of something you will use.
Embody is cheaper. Does that make it better?
Maximus charges $133/mo where Embody charges $69/mo. A premium is defensible only if it maps to something specific, so here is what Maximus puts behind it: prescriptions approved by licensed doctors, filled through U.S. pharmacies, and home delivery.
Embody's answer is the lowest published semaglutide price on this list, with no lock-in. What it does not carry: a limited-time rate with few of the extras that higher-priced platforms bundle.
Price gaps in this market rarely reflect a different molecule; they reflect a different amount of human contact. Decide how much of that you actually intend to use before paying for it.
How Embody works
Semaglutide $69/mo (was $299), Tirzepatide $119/mo In this pairing, its distinguishing feature is the lowest published semaglutide price on this list, with no lock-in.
The process is licensed provider review handled entirely online, then free shipping, 1-2 day delivery after approval. On money, expect published rate per medication — published upfront.
Support: 24/7 support for dosing and side-effect questions. The medications on offer are compounded semaglutide and compounded tirzepatide.
Embody pros
- No long-term commitment; cancel without penalty
- Free shipping with fast 1–2 day delivery after approval
- Compounded tirzepatide available at $119/month
- Lowest entry price on this list at $69/month for compounded semaglutide
Embody cons
- Final pricing may vary based on dose and clinician recommendation
- $69 semaglutide pricing is a limited-time offer that may increase
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
Set beside Maximus, the thing to weigh: a limited-time rate with few of the extras that higher-priced platforms bundle.
Maximus: what you are buying
$132.99 per Month What it is really selling here is a low flat rate with a simple direct-pay structure and nothing bolted on.
You start with telemedicine intake, no clinic visits; medication arrives via home delivery. The price behaves as flat rate at every dose.
Prescriptions approved by licensed doctors, filled through U.S. pharmacies. The formulary covers compounded semaglutide.
Maximus pros
- Prescriptions approved by licensed doctors
- Medication filled through trusted U.S. pharmacies
- Low flat rate at $132.99/month
- Convenient telemedicine access with no clinic visits
Maximus cons
- No published outcome or weight loss guarantee
- Limited published detail on tirzepatide availability and program features
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
Against Embody specifically, the trade you are making: the smallest patient base here, with limited published detail on tirzepatide.
Picking between them
Choose Embody if:
- delivery works the way you want it to: free shipping, 1-2 day delivery after approval
- you want to start on their timeline: licensed provider review handled entirely online
- the level of clinical contact suits you: 24/7 support for dosing and side-effect questions
- you would get real value from the lowest published semaglutide price on this list, with no lock-in
Choose Maximus if:
- you would get real value from a low flat rate with a simple direct-pay structure and nothing bolted on
- you want the price you sign up at to survive titration
- you want to start on their timeline: telemedicine intake, no clinic visits
- the level of clinical contact suits you: prescriptions approved by licensed doctors, filled through U.S. pharmacies
The compromises on both sides
On price. The monthly gap is 93% in Embody's favor. Whether that is a saving or a false economy turns on one thing: a limited-time rate with few of the extras that higher-priced platforms bundle.
On commitment. Neither publishes a multi-month discount, so both are month-to-month decisions and neither asks you to prepay for a response you have not had yet. Neither publishes financing options, so plan for the full amount each month.
On medication. Embody covers compounded semaglutide and compounded tirzepatide; Maximus covers compounded semaglutide. Only Embody publishes a tirzepatide route, which matters if semaglutide underdelivers.
On clinical contact. Embody provides 24/7 support for dosing and side-effect questions. Maximus provides prescriptions approved by licensed doctors, filled through U.S. pharmacies. Both are asynchronous-first services and neither replaces a physician who can examine you.
The medication, not the platform
Both platforms sell access to the same drug class, so the clinical record below applies equally to each.
SURMOUNT-4 found that continuing tirzepatide maintained and extended weight reduction, while withdrawing it led to substantial regain, per JAMA, SURMOUNT-4.
The SELECT trial found semaglutide reduced major adverse cardiovascular events in adults with overweight or obesity and established cardiovascular disease, without diabetes, per NEJM, SELECT.
Which is to say: the medication decision belongs with a clinician, and the platform decision belongs with a spreadsheet.
Embody vs Maximus: common questions
Are Embody and Maximus legitimate?
Both are licensed telehealth platforms that route a prescription through a clinician review before anything is dispensed; neither sells medication without one. Embody operates on published rate per medication with pricing published upfront, Maximus on flat rate at every dose, published upfront. The meaningful due diligence is on the medication category and the terms, not on whether the platforms are real.
What happens if I stop taking the medication?
Both programs are month to month, which makes stopping easy and makes the consequence of stopping the thing to plan for: published extension data shows most of the lost weight returns within about a year. That is an argument for choosing on annual cost rather than entry price.
Is Embody or Maximus better for a first GLP-1 prescription?
First-timers usually get more from clinical access than from a lower rate, because the first two months are where most people stop. On that basis Embody has the stronger case; after month three, cost should take over.
Can I switch from Embody to Maximus later?
Nothing stops you. The friction is administrative rather than clinical: a new intake, a new prescriber, and a delivery gap if you time it badly. Move while you still have two weeks of medication in the fridge.
Does Embody or Maximus offer tirzepatide?
Embody does, at $119/mo. Maximus publishes compounded semaglutide only, so moving to tirzepatide would mean moving provider — a new intake, a new price, and the loss of any rate you had locked in.
The verdict
Embody is the cheaper year by $768, and for a straightforward course of treatment that settles it.
Where Maximus justifies itself is a low flat rate with a simple direct-pay structure and nothing bolted on. Where it does not is anywhere the extra spend buys features you will never open.
Whichever you choose, diarise the month the introductory pricing ends and re-run the comparison then. Neither platform will remind you.
Keep comparing
- Embody vs Mochi HealthTirzepatide access
- Embody vs Elevate HealthBudget vs premium
- Directmeds vs MaximusPublished price vs quote-only
- Enhance MD vs MaximusBudget vs premium
- altRx vs LIV BodyBudget vs premium
- altRx vs IVIM HealthBudget vs premium
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by Embody or Maximus, and does not sell treatment. Read our ranking methodology.